Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
We have purified and characterized a novel conotoxin from the venom of Conus obscurus, which has the unique property of selectively and potently inhibiting the fetal form of the mammalian neuromuscular nicotinic acetylcholine receptor (nAChR) (alpha1beta1gammadelta-subunits). Although this conotoxin, alphaA-conotoxin OIVB (alphaA-OIVB), is a high-affinity antagonist (IC50 of 56 nm) of the fetal muscle nAChR, it has >1800-fold lower affinity for the adult muscle nAChR (alpha1beta1epsilondelta-subunits) and virtually no inhibitory activity at a high concentration on various neuronal nAChRs (IC50 > 100 microm in all cases). The peptide (amino acid sequence, CCGVONAACPOCVCNKTCG), with three disulfide bonds, has been chemically synthesized in a biologically active form. Although the neuromuscular nAChRs are perhaps the most extensively characterized of the receptors/ion channels of the nervous system, the precise physiological roles of the fetal form of the muscle nAChR are essentially unknown.alphaA-OIVB is a potentially important tool for delineating the functional roles ofalpha1beta1gammadelta receptors in normal development, as well as in various adult tissues and in pathological states. In addition to its potential as a research tool, alphaA-OIVB may have some direct biomedical applications.
Blount,
Molecular basis of the two nonequivalent ligand binding sites of the muscle nicotinic acetylcholine receptor.
1989, Pubmed
Blount,
Molecular basis of the two nonequivalent ligand binding sites of the muscle nicotinic acetylcholine receptor.
1989,
Pubmed Bren,
Identification of residues in the adult nicotinic acetylcholine receptor that confer selectivity for curariform antagonists.
1997,
Pubmed Cartier,
A new alpha-conotoxin which targets alpha3beta2 nicotinic acetylcholine receptors.
1996,
Pubmed
,
Xenbase CHANG,
ISOLATION OF NEUROTOXINS FROM THE VENOM OF BUNGARUS MULTICINCTUS AND THEIR MODES OF NEUROMUSCULAR BLOCKING ACTION.
1963,
Pubmed Changeux,
The functional architecture of the acetylcholine nicotinic receptor explored by affinity labelling and site-directed mutagenesis.
1992,
Pubmed ELLMAN,
Tissue sulfhydryl groups.
1959,
Pubmed Gattenloehner,
A comparison of MyoD1 and fetal acetylcholine receptor expression in childhood tumors and normal tissues: implications for the molecular diagnosis of minimal disease in rhabdomyosarcomas.
1999,
Pubmed Gattenloehner,
The fetal form of the acetylcholine receptor distinguishes rhabdomyosarcomas from other childhood tumors.
1998,
Pubmed Gattenlöhner,
Expression of foetal type acetylcholine receptor is restricted to type 1 muscle fibres in human neuromuscular disorders.
2002,
Pubmed Groebe,
alpha-Conotoxins selectively inhibit one of the two acetylcholine binding sites of nicotinic receptors.
1995,
Pubmed Gu,
Characterization of acetylcholine receptor subunits in developing and in denervated mammalian muscle.
1988,
Pubmed Hopkins,
A new family of Conus peptides targeted to the nicotinic acetylcholine receptor.
1995,
Pubmed Horton,
The 'embryonic' gamma subunit of the nicotinic acetylcholine receptor is expressed in adult extraocular muscle.
1993,
Pubmed Jacobsen,
Differential targeting of nicotinic acetylcholine receptors by novel alphaA-conotoxins.
1997,
Pubmed
,
Xenbase Jones,
The nicotinic acetylcholine receptor gene family of the pufferfish, Fugu rubripes.
2003,
Pubmed Marx,
Proteins with epitopes of the acetylcholine receptor in epithelial cell cultures of thymomas in myasthenia gravis.
1989,
Pubmed McArdle,
Waglerin-1 selectively blocks the epsilon form of the muscle nicotinic acetylcholine receptor.
1999,
Pubmed Miller,
Peptide chemistry: development of high performance liquid chromatography and capillary zone electrophoresis.
1996,
Pubmed Miller,
Analysis of synthetic peptides by capillary zone electrophoresis in organic/aqueous buffers.
1998,
Pubmed Mishina,
Molecular distinction between fetal and adult forms of muscle acetylcholine receptor.
,
Pubmed
,
Xenbase Navaneetham,
Human thymuses express incomplete sets of muscle acetylcholine receptor subunit transcripts that seldom include the delta subunit.
2001,
Pubmed Osaka,
Subunit interface selectivity of the alpha-neurotoxins for the nicotinic acetylcholine receptor.
1999,
Pubmed Sine,
Molecular dissection of subunit interfaces in the acetylcholine receptor: identification of determinants of alpha-conotoxin M1 selectivity.
1995,
Pubmed Sine,
Molecular dissection of subunit interfaces in the acetylcholine receptor: identification of residues that determine curare selectivity.
1993,
Pubmed Teichert,
AlphaA-Conotoxin OIVA defines a new alphaA-conotoxin subfamily of nicotinic acetylcholine receptor inhibitors.
2004,
Pubmed Witzemann,
Developmental regulation of five subunit specific mRNAs encoding acetylcholine receptor subtypes in rat muscle.
1989,
Pubmed Witzemann,
Differential regulation of muscle acetylcholine receptor gamma- and epsilon-subunit mRNAs.
1987,
Pubmed
